Related Experiment Video
Updated: Jun 17, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Papillary thyroid microcarcinoma: Does management differ based on facility variables?
Ryan C Higgins1, Tonya S King2, Jacqueline Tucker3
1Department of Otolaryngology, University of Nebraska Medical Center, Omaha, NE, United States of America.
Despite guidelines recommending conservative care for papillary thyroid microcarcinoma (mPTC), most patients undergo total thyroidectomy. Treatment decisions for mPTC are influenced by facility volume, not solely patient factors.
Area of Science:
- Endocrinology
- Surgical Oncology
- Public Health
Background:
- Papillary thyroid carcinoma (PTC) detection rates have significantly increased.
- Papillary thyroid microcarcinoma (mPTC) is an indolent form of PTC.
- The American Thyroid Association (ATA) recommends conservative management for mPTC.
Purpose of the Study:
- To investigate the management of mPTC.
- To analyze the impact of facility variables on mPTC treatment.
- To compare treatment modalities before and after the 2015 ATA guidelines.
Main Methods:
- Retrospective observational study using the National Cancer Database (2004-2018).
- Collected data on patient demographics, tumor characteristics, facility volume, and treatment.
- Compared conservative vs. non-conservative treatments based on patient and facility factors.
Main Results:
- Total thyroidectomy with or without radioactive iodine ablation (RAI) is the predominant treatment.
- Patients at low-volume facilities were more likely to receive conservative treatment.
- Treatment patterns remained largely consistent regardless of patient or facility characteristics.
Conclusions:
- Current treatment for mPTC often deviates from 2015 ATA recommendations.
- Total thyroidectomy is frequently performed, particularly at high-volume facilities.
- Facility volume appears to influence the degree of surgical intervention for mPTC.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023